Lojabark

Cinchona officinalis, commonly known as the cinchona tree or Peruvian bark, is a traditional medicinal plant native to South America. Its use in folk medicine spans centuries and has been particularly significant in indigenous and traditional South American healing practices for treating fevers and malaria. While its traditional applications are well-documented, scientific evidence supporting these uses remains limited. Research indicates that cinchona leaf extract may have some potential against multidrug-resistant Pseudomonas aeruginosa, showing improved antibiotic activity, though further investigation is warranted to confirm these findings. Additionally, two quinine-chalcone hybrids derived from the plant exhibited potent cytotoxic and antiproliferative effects in EBC-1 cells, suggesting possible anti-cancer properties. Cinchonine, another compound found in cinchona, has shown multiple biological activities including anti-inflammatory and anti-obesity effects; however, more clinical research is needed to explore its potential applications. In vitro studies have also demonstrated that homeopathic preparations of Cinchona officinalis (CO)-MT can inhibit SARS-CoV-2 infection by 89%, comparable to remdesivir. Nonetheless, these findings are preliminary and require further validation through larger-scale clinical trials. Safety concerns for cinchona use appear minimal based on current data; however, no major issues have been recorded. There is also no reported evidence of significant drug interactions with cinchona, though this should be monitored in future research as more comprehensive studies become available.

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.